Leopan, John L.

HRN: 22-00-61  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/01/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/01/2022
10/08/2022
IV
1.5h
Q6
Infected Wound; CAP MR
Waiting Final Action 
10/01/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/01/2022
10/08/2022
IV
600mg
Q6
Infected Wound; CAP MR
Waiting Final Action 
10/01/2022
MUPIROCIN 2%, 15G (TUBE)
10/01/2022
10/08/2022
TOPICAL
2%
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: